Zebrafish models of myeloid malignancies produced through tet2 and asxl1 genomic editing

被引：0
|
作者：
Gjini, Evisa [1 ]
Mansour, Marc [1 ]
Sander, Jeffry [2 ]
He, Shuning [1 ]
Ko, Myunggon [3 ]
Zhou, Yi [4 ]
Rodig, Scott [5 ]
Joung, Keith [6 ]
Zon, Leonard [4 ]
Rao, Anjana [3 ]
Look, Thomas [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] La Jolla Inst Allergy & Immunol, La Jolla, CA USA
[4] Childrens Hosp, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Boston, MA 02115 USA
[6] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-5152
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5152
引用
收藏
页数：2
相关论文
共 50 条
  • [31] ASXL1/ TET2 Genotype-Based Risk Stratification Outperforms ASXL1 Mutational Impact and Is Independent of Mutant Variant Allele Fractions (VAF) in CMML
    Csizmar, Clifford M.
    Gurney, Mark
    Kanagal-Shamanna, Rashmi
    Chien, Kelly S.
    Hammond, Danielle E.
    Lasho, Terra L.
    Finke, Christy M.
    Dean, Christopher
    Mangaonkar, Abhishek A.
    Gangat, Naseema
    Tefferi, Ayalew
    Alkhateeb, Hassan
    Garcia-Manero, Guillermo
    Montalban-Bravo, Guillermo
    Patnaik, Mrinal M.
    BLOOD, 2023, 142
  • [32] Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies
    Yang, Hui
    Kurtenbach, Stefan
    Guo, Ying
    Lohse, Ines
    Durante, Michael A.
    Li, Jianping
    Li, Zhaomin
    Al-Ali, Hassan
    Li, Lingxiao
    Chen, Zizhen
    Field, Matthew G.
    Zhang, Peng
    Chen, Shi
    Yamamoto, Shohei
    Li, Zhuo
    Zhou, Yuan
    Nimer, Stephen D.
    Harbour, J. William
    Wahlestedt, Claes
    Xu, Mingjiang
    Yang, Feng-Chun
    BLOOD, 2018, 131 (03) : 328 - 341
  • [33] Analysis of ASXL1 Mutated T Cells in Patients with Myeloid Malignancies
    Fernandez, Eduardo
    Sanchez, Jesse
    Liang, Gangning
    Pospiech, Mateusz
    Li, Hongtao
    Manojlovic, Zarko
    Alachkar, Houda
    O'Connell, Casey L.
    BLOOD, 2023, 142
  • [34] ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia
    Csizmar, Clifford M.
    Gurney, Mark
    Kanagal-Shamanna, Rashmi
    Chien, Kelly
    Hammond, Danielle
    Lasho, Terra L.
    Finke, Christy M.
    Dean, Christopher
    Natu, Anuya
    Mangaonkar, Abhishek A.
    Al-Kali, Aref
    Gangat, Naseema
    Tefferi, Ayalew
    Alkhateeb, Hassan
    Garcia-Manero, Guillermo
    Komrokji, Rami S.
    Ali, Najla A.
    Padron, Eric
    Montalban-Bravo, Guillermo
    Patnaik, Mrinal M.
    HAEMATOLOGICA, 2024, 109 (10) : 3419 - 3425
  • [35] TET2, ASXL1, IDH1 AND IDH2 MUTATIONS IN NON-CML MYELOPROLIFERATIVE NEOPLASMS
    Soyer, N. Akad
    Kaymaz, B. Tezcanli
    Ozkan, M. Comert
    Aktan, C.
    Sahin, F.
    Kosova, B.
    Saydam, G.
    LEUKEMIA RESEARCH, 2014, 38 : S46 - S47
  • [36] Similarities and Differences of DNMT3A, TET2 and ASXL1 Mutations across Ccus, MDS and AML
    Huber, Sandra
    Hutter, Stephan
    Baer, Constance Regina
    Meggendorfer, Manja
    Hoermann, Gregor
    Kern, Wolfgang
    Haferlach, Torsten
    Haferlach, Claudia
    BLOOD, 2024, 144 : 1820 - 1820
  • [37] MUTATIONS OF TET2, ASXL1, CBL AND IDH1 IN MYELOFIBROTIC TRANSFORMATION OF ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA
    Aviles, L. Martinez
    Besses, C.
    Alvarez-Larran, A.
    Pons, A.
    Serrano, S.
    Bellosillo, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 403 - 403
  • [38] TET2 rs2454206, TET2 rs12498609 and ASXL1 rs3746609 single nucleotide polymorphisms in patients with myelodysplastic syndromes
    Hu, Jinjun
    Xu, Jing
    Tian, Tingting
    Xie, Juan
    Fan, Lifang
    Zhu, Guiyang
    Xia, Ting
    Chen, Xi
    Tan, Yanhong
    Chen, Xiuhua
    Ren, Fanggang
    Zhang, Yaofang
    Wang, Hongwei
    Xu, Zhifang
    BLOOD CELLS MOLECULES AND DISEASES, 2019, 74 : 44 - 50
  • [39] Cooperative effects of BCOR and TET2 mutations in myeloid malignancies
    Schaefer, E. J.
    Fares, I.
    Cejas, P.
    Font-Tello, A.
    Meyer, C. A.
    Long, H. W.
    Lindsley, R. C.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 18 - 18
  • [40] TET2 gene harbors mutations associated with myeloid malignancies
    Jankowska, A. M.
    Szpurka, H.
    Tiu, R. V.
    Makishima, H.
    Afable, M.
    Huh, J.
    O'Keefe, C.
    Ganetzky, R.
    McDevitt, M. A.
    Maciejewski, J. P.
    LEUKEMIA RESEARCH, 2009, 33 : S84 - S84
12345